NextCure, Inc.
Regulated industryPhysical productsDevelopment stageTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $6.89
- 52-Week Range
- $1.55 – $15.74
- Market Cap
- $31.05M
- P/E (TTM)
- —
- EPS (TTM)
- -6.78
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 5.64
- PEG Ratio
- —
- Return on Equity
- -281.11%
- Return on Assets
- -98.46%
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Profit Margin
- 0.00%
- Current Ratio
- 2.31
- Debt/Equity
- 0.38
- Total Debt
- $0.00
- Free Cash Flow
- $-25.34M
- Revenue Growth
- —
- Earnings Growth
- —
- Enterprise Value
- $22.80M
Market Snapshot
About
NextCure is an immuno-oncology biotechnology company developing novel immunomedicines to treat cancer and other immune-related diseases. The company focuses on modulating the immune system to improve patient outcomes.